Lee Han Hee, Choi Yoon Young, Choi Myung-Gyu
Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
J Neurogastroenterol Motil. 2014 Apr 30;20(2):152-62. doi: 10.5056/jnm.2014.20.2.152.
BACKGROUND/AIMS: Hypnotherapy is considered as a promising intervention for irritable bowel syndrome (IBS), but the evidence is still limited. The aims of this study were to conduct a systematic review and meta-analysis to estimate the efficacy of hypnotherapy for the treatment of IBS.
A literature search was performed using MEDLINE (PubMed), Embase, PsycINFO and the Cochrane Central Register of Controlled Trials (CENTRAL database). Only randomized controlled trials that compared hypnotherapy with any other conven-tional treatment or no treatment in patients with IBS were included. Studies had to report outcomes as IBS symptom score or quality of life. The mean change in outcome score was used to pool these outcomes for the meta-analysis. Data were syn-thesized using the standardized mean difference for continuous data.
Seven randomized controlled trials (6 papers) involving 374 patients with IBS were identified. Performance bias was high in all trials because it was impossible to blind participants and therapists in this type of intervention. The outcomes in this meta-anal-ysis were evaluated at 3 months for short-term effects and at 1 year for long-term effects. The change in abdominal pain score at 3 months was significant in the hypnotherapy group (standardized mean difference, -0.83; 95% CI, -1.65 to -0.01). Three of the 4 trials showed greater improvement in overall gastrointestinal symptoms in the hypnotherapy group.
This study provides clearer evidence that hypnotherapy has beneficial short-term effects in improving gastrointestinal symptoms of patients with IBS.
背景/目的:催眠疗法被认为是治疗肠易激综合征(IBS)的一种有前景的干预方法,但证据仍然有限。本研究的目的是进行一项系统评价和荟萃分析,以评估催眠疗法治疗IBS的疗效。
使用MEDLINE(PubMed)、Embase、PsycINFO和Cochrane对照试验中央注册库(CENTRAL数据库)进行文献检索。仅纳入将催眠疗法与IBS患者的任何其他传统治疗或不治疗进行比较的随机对照试验。研究必须将结局报告为IBS症状评分或生活质量。结局评分的平均变化用于汇总这些结局以进行荟萃分析。连续数据使用标准化均数差进行数据合并。
共纳入7项随机对照试验(6篇论文),涉及374例IBS患者。由于在这类干预中不可能使参与者和治疗师盲法,所有试验中的实施偏倚都很高。本荟萃分析的结局在3个月时评估短期效应,在1年时评估长期效应。催眠疗法组在3个月时腹痛评分的变化具有显著性(标准化均数差,-0.83;95%CI,-1.65至-0.01)。4项试验中的3项显示催眠疗法组在总体胃肠道症状方面改善更大。
本研究提供了更明确的证据,表明催眠疗法在改善IBS患者胃肠道症状方面具有有益的短期效应。